A Reductionist View of Alzheimer's Disease

Accounts of Chemical Research

Volumn 29, Issue 7, 1996, Pages 317-321

  Lansbury Jr , Peter T ^{a,b,c,d,e,f,g}  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e PRINCETON UNIVERSITY   (United States)

^f HARVARD UNIVERSITY   (United States)

^g ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001193811     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar950159u     Document Type: Article

References (64)

1. Alzheimer, A. Alg. Z. Psychiatry 1907, 64, 146-8.
2. Schellenberg, G. D. Proc. Natl. Acad. Sci. U.S.A. 1995,92, 8552-59.
3. Selkoe, D. J. J. NIH Res. 1995, 7, 57-64.
4. Kosik, K. S. J. Cell. Biol. 1994, 127, 1501-4.
5. Selkoe, D. J. Neuron 1991, 6, 487-498.
6. 36,43 has recently been identified and will be discussed later in the text.
7. Games, D.; Adams, D.; Alessandrini, R.; Barbour, R.; Berthelette, P.; Blackwell, C.; Carr, T.; Clemens, J.; Donaldson, T.; Zhao, J.; et al. Nature 1995, 373, 523-527. Other recent efforts to produce mouse models: LaFerla, F. M.; Tinkle, B. T.; Bieberich, C. J.; Haudenschild, C. C.; Jay, G. Nature Genet. 1995, 9, 21-30. Hsiao, K. K.; et al. Neuron 1995, 15, 1203-18. These animals show neurological abnormalities, but no animal demonstrates an AD-like condition. It should be emphasized that the mouse version of AD has not been reported, despite the fact that mice express APP.
8. Games, D.; Adams, D.; Alessandrini, R.; Barbour, R.; Berthelette, P.; Blackwell, C.; Carr, T.; Clemens, J.; Donaldson, T.; Zhao, J.; et al. Nature 1995, 373, 523-527. Other recent efforts to produce mouse models: LaFerla, F. M.; Tinkle, B. T.; Bieberich, C. J.; Haudenschild, C. C.; Jay, G. Nature Genet. 1995, 9, 21-30. Hsiao, K. K.; et al. Neuron 1995, 15, 1203-18. These animals show neurological abnormalities, but no animal demonstrates an AD-like condition. It should be emphasized that the mouse version of AD has not been reported, despite the fact that mice express APP.
9. Games, D.; Adams, D.; Alessandrini, R.; Barbour, R.; Berthelette, P.; Blackwell, C.; Carr, T.; Clemens, J.; Donaldson, T.; Zhao, J.; et al. Nature 1995, 373, 523-527. Other recent efforts to produce mouse models: LaFerla, F. M.; Tinkle, B. T.; Bieberich, C. J.; Haudenschild, C. C.; Jay, G. Nature Genet. 1995, 9, 21-30. Hsiao, K. K.; et al. Neuron 1995, 15, 1203-18. These animals show neurological abnormalities, but no animal demonstrates an AD-like condition. It should be emphasized that the mouse version of AD has not been reported, despite the fact that mice express APP.
10. Seubert, P.; Vigo-Pelfrey, C.; Esch, F.; Lee, M.; Dovey, H.; Davis, D.; Sinha, S.; Schlossmacher, M.; Whaley, J.; Swindlehurst, C.; McCormack, R.; Wolfert, R.; Selkoe, D.; Lieberburg, I.; Schenk, D. Nature 1992, 359, 325-327.
11. Jarrett, J. T.; Berger, E. P.; Lansbury, P. T., Jr. Biochemistry 1993, 32, 4693-97.
12. Jarrett, J. T.; Lansbury, P. T., Jr. Cell 1993, 73, 1055-58.
13. 61,62
14. Barrow, C. J.; Zagorski, M. G. Science 1991, 253, 179-182.
15. Barrow, C. J.; Yasuda, A.; Kenny, P. T. M.; Zagorski, M. G. J. Mol. Biol. 1992, 225, 1075-1093.
16. Zagorski, M. G.; Barrow, C. J. Biochemistry 1992, 31, 5621-5631.
17. Soreghan, B.; Kosmoski, J.; Glabe, C. J. Biol. Chem. 1994, 269, 28551-28554.
18. Halverson, K.; Fraser, P. E.; Kirschner, D. A.; Lansbury, P. T., Jr. Biochemistry 1990, 29, 2639-2644.
19. Jarrett, J. T.; Costa, P. R.; Griffin, R. G.; Lansbury, P. T., Jr. J. Am. Chem. Soc. 1994, 116, 9741-9742. This paper reports that C-terminal truncation of peptide models of the β protein slightly increases the solubility of the resultant amyloid fibrils in part, by slowing the disaggregation rate.
20. Younkin, S.; et al. Unpublished results. We thank Dr. Younkin for sharing this information with us prior to its publication.
21. Iwatsubo, T.; Odaka, A.; Suzuki, N.; Mizusawa, H.; Nukina, N.; Ihara, Y. Neuron 1994, 13, 45-53.
22. Kirschner, D. A.; Abraham, C.; Selkoe, D. J. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 503-507.
23. Marsh, R. E.; Corey, R. B.; Pauling, L. Acta. Crystallogr. 1955, 8, 710-715.
24. Lansbury, P. T., Jr. Biochemistry 1992, 31, 6865-6870.
25. Halverson, K. H.; Sucholeiki, I.; Ashburn, T. T.; Lansbury, P. T., Jr. J. Am. Chem. Soc. 1991, 113, 6701-6703.
26. Bandekar, J.; Krimm, S. Int. J. Peptide Protein Res. 1985, 26, 407-415.
27. 23
28. Krimm, S.; Bandekar, J. In Advances in Protein Chemistry; Anfinsen, C., Ed.; 1986; Vol. 38, pp 183-364.
29. Ashburn, T. T.; Auger, M.; Lansbury, P. T., Jr. J. Am. Chem. Soc. 1992, 114, 790.
30. Raleigh, D. P.; Creuzet, F.; Das Gupta, S. K.; Levitt, M. H.; Griffin, R. G. J. Am. Chem. Soc. 1989, 111, 4502-4503.
31. Griffiths, J. M.; Ashburn, T. T.; Auger, M.; Costa, P. R.; Griffin, R. G.; Lansbury, P. T., Jr. J. Am. Chem. Soc, 1995, 117, 3539-3546.
32. Lansbury, P. T., Jr.; Costa, P. R.; Griffiths, J. M.; Simon, E. J.; Auger, M.; Halverson, K. J.; Kocisko, D. A.; Hendsch, Z. S.; Ashburn, T. T.; Spencer, R. G. S.; Tidor, B.; Griffin, R. G. Nature Struct. Biol. 1995, 2, 990-8.
33. Spencer, R. G. S.; Halverson, K. J.; Auger, M.; McDermott, A. E.; Griffin, R. G.; Lansbury, P. T., Jr. Biochemistry 1991, 30, 10382.
34. Haass, C.; Schlossmacher, M. G.; Hung, A. Y.; Vigo-Pelfrey, C.; Mellon, A.; Ostaszewski, B. L.; Lieberburg, I.; Koo, E. H.; Schenk, D.; Teplow, D. B.; Selkoe, D. J. Nature 1992, 359, 322-325.
35. Shoji, M.; Golde, T. E.; Ghiso, J.; Cheung, T. T.; Estus, S,; Shaffer, L. M.; Cai, X.-D.; McKay, D. M.; Tintner, R.; Frangione, B.; Younkin, S. G. Science 1992, 258, 126-129.
36. Jarrett, J. T.; Lansbury, P. T., Jr. Biochemistry 1992, 31, 12345.
37. Ashburn, T. T.; Lansbury, P. T., Jr. J. Am. Chem. Soc. 1993, 115, 11012.
38. Han, H.; Weinreb, P. H.; Lansbury, P. T., Jr. Chem. Biol. 1995, 2, 163-9.
39. Come, J. H.; Fraser, P. E.; Lansbury, P. T., Jr. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 5959-5963.
40. Come, J. H.; Lansbury, P. T., Jr. J. Am. Chem. Soc. 1994, 116, 4109-4110.
41. Cai, X.-D.; Golde, T. E.; Younkin, S. G. Science 1993, 259, 514-516.
42. Suzuki, N.; Cheung, T. T.; Cai, X.-D.; Odaka, A.; Otvos, L., Jr.; Eckman, C.; Golde, T. E.; Younkin, S. G. Science 1994, 264, 1336-1340.
43. Sherrington, R.; Rogaev, E. I.; Liang, Y.; Rogaeva, E. A.; St. George-Hyslop, P. H. Nature 1995, 375, 754-760.
44. Corder, E. H.; Saunders, A. M.; Strittmatter, W. J.; Schmechel, D. E.; Gaskell, P. C.; Small, G. W.; Roses, A. D.; Haines, J. L.; Pericak-Vance, M. A. Science 1993, 261, 921-923.
45. Ueda, K.; Fukushima, H.; Masliah, E.; Xia, Y.; Iwai, A.; Yoshimoto, M.; Otero, D. A. C.; Kondo, J.; Ihara, Y.; Saitoh, T. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 11282-11286.
46. Iwai, A.; Masliah, E.; Yoshimoto, M.; Ge, N.; Flanagan, L.; Rohan de Silva, H. A.; Kittel, A.; Saitoh, T. Neuron 1995, 14, 467-475.
47. George, J. M.; Jin, H.; Woods, W. S.; Clayton, D. F. Neuron 1995, 15, 361-72.
48. Any arguments based on age of AD onset should be viewed with suspicion; it would be more accurate to refer to the age of AD detection. The clinical heterogeneity of AD, and the lack of any biochemical markers for diagnosis during the life of the patient, makes it difficult to determine the time course of AD pathogenesis.
49. Hyman, B. T.; West, H. L.; Rebeck, G. W.; Buldyrev, S. V.; Mantegna, R. N.; Ukleja, M.; Havlin, S.; Stanley, H. E. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 3586-90.
50. Ma, J.; Yee, A.; Brewer, H. B.; Das, S.; Potter, H. Nature 1994, 372, 92-4.
51. Sanan, D. A.; Weisgraber, K. H.; Russell, S. J.; Mahley, R. W.; Huang, D.; Saunders, A.; Schmechel, D.; Wisniewski, T.; Frangione, B.; Roses, A. D.; Strittmatter, W. J. J. Clin. Invest. 1994, 94, 860-869.
52. 51 However, the morphology of the amyloid fibrils may be critical for the understanding of the pathogenesis.
53. Evans, K. C.; Berger, E. P.; Cho, C.-G.; Weisgraber, K. H.; Lansbury, P. T., Jr. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 763-767.
54. Chan, W.; Wood, S. J.; Wetzel, R.; Fornwald, J.; Brawner, M. Unpublished results. We thank Dr. Wetzel for sharing his results with us prior to publication.
55. Griffiths, J. M.; Ashburn, T. T.; Auger, M.; Costa, P. R.; Griffin, R. G.; Lansbury, P. T., Jr. J. Am. Chem. Soc. 1995, 117, 3539-46.
56. Dunitz, J. D.; Bernstein, J. Acc. Chem. Res. 1995, 28, 193-200.
57. Bessen, R. A.; Kocisko, D. A.; Raymond, G. J.; Nandan, S.; Lansbury, P. T., Jr.; Caughey, B. Nature 1995, 375, 698-700.
58. Kamboh, M. I.; Sanghera, D. K.; Ferrell, R. E.; DeKosky, S. T. Nature Genet. 1995, 10,
59. Fraser, P. E.; Nguyen, J. T.; McLachlan, D. R.; Abraham, C. R.; Kirschner, D. A. J. Neurochem. 1993, 61, 298-305.
60. Ericksson, S.; Janciauskiene, S.; Lannfelt, L. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 2313-17.
61. Bush, A. I.; Pettingell, W. H.; Multhap, G.; Paradis, M. D.; Vonsattel, J.-P.; Gusella, J. F.; Beyreuther, K.; Masters, C. L.; Tanzi, R. E. Science 1994, 265, 1464-7.
62. Manyth, P. W.; Ghilardi, J. R.; Rogers, S.; DeMaster, E.; Allen, C. J.; Stimson, E. R.; Maggio, J. E. J. Neurochem. 1993, 61, 1171-74.
63. Gupta-Bansal, R.: Frederickson, R. C. A.; Brunden, K. R. J. Biol. Chem. 1995, 270, 18666-671.
64. Tennent, G. A.; Lovat, L. B.; Pepys, M. B. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 4299-4303.